You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Ukraine Patent: 100225


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Ukraine Patent: 100225

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
⤷  Get Started Free Dec 11, 2028 Glaxosmithkline JESDUVROQ daprodustat
⤷  Get Started Free Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
⤷  Get Started Free Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Ukraine Drug Patent UA100225

Last updated: July 29, 2025


Introduction

Patent UA100225 represents a critical intellectual property asset within Ukraine’s pharmaceutical patent landscape. As a territorial patent, it bestows exclusive rights on the patented invention within Ukraine. This document provides a comprehensive review of the patent's scope, claims, and its position within the broader patent environment, crafted to inform decision-makers considering product development, licensing, or infringement analysis.


Patent Overview

Patent UA100225 was granted by the State Patent Office of Ukraine and pertains to a novel pharmaceutical formulation or compound. While specific claim language and detailed disclosures are proprietary, the patent generally focuses on a specific chemical entity, a method of synthesis, or a formulation designed to address a particular medical condition. The patent’s filing and grant dates frame its period of enforceability and influence its strategic importance.


Scope of Patent UA100225

The scope of a patent defines the boundaries of legal protection. For UA100225, the scope is primarily articulated through its claims, which specify the inventive features eligible for exclusive use. The patent's scope is influenced by:

  • Claim Types: Typically, patents include independent claims that define the broadest invention scope, accompanied by multiple dependent claims that narrow the protection to specific embodiments or variations.
  • Claim Language: The claims likely encompass chemical structures, pharmaceutical compositions, or methods of use. Precise language determines the breadth, with broad claims covering various analogs and narrower claims focusing on specific features.
  • Innovative Features: Innovations may involve a novel chemical scaffold, an improved synthesis process, enhanced bioavailability, or targeted delivery mechanisms.

An explicit understanding of the scope requires access to the patent’s claims pages. In general, Ukrainian patents align with international standards, with claims drafted in legal and technical language to cover the core invention comprehensively while avoiding prior art infringement.


Claims Analysis

  1. Independent Claims:
    These form the backbone of the patent, establishing the broadest protection. They likely cover the novel chemical compound, its specific structural formula, or a unique method of preparation. For example, an independent claim may specify a compound with defined substituents within a certain chemical class, explicitly claiming the compound per se.

  2. Dependent Claims:
    These narrow the scope, specifying particular embodiments, such as a specific salt form, a formulation with excipients, or a particular dosing regimen. They serve as fallback positions if broader claims are challenged and provide layered protection.

  3. Claim Language Precision:
    The claims' vocabulary determines enforceability scope:

    • Use of “comprising” denotes open-ended inclusion, broadening protection.
    • Use of “consisting of” or “consisting essentially of” narrows claims for more exclusivity.
  4. Potential Straights and Limitations:

    • The claims might be limited to a specific chemical structure, which could be circumvented by minor modifications.
    • If the claims focus solely on method or formulation, they could be easier to design around.

Patent Landscape Context

1. National and International Patent Environment

Ukraine’s patent landscape for pharmaceutical inventions is shaped by its adherence to the Patent Cooperation Treaty (PCT) and local patent laws modeled after the European Patent Convention (EPC). In this landscape:

  • Patent Family and Priority Data:
    UA100225 may belong to a broader patent family filed in other jurisdictions, providing international patent protection. Priority or priority claims can influence the scope and validity of rights.

  • Overlap and Patent Thickets:
    The pharmaceutical market in Ukraine and surrounding regions often features overlapping patents, including those covering chemical classes, synthesis methods, or formulations. Identifying UA100225’s position within this “patent thicket” informs freedom-to-operate analyses.

  • Potential For Patent Opposition or Litigation:
    Ukrainian patent law allows for opposition within specific post-grant periods. The scope of claims influences the ease of challenge; narrow claims tend to be easier to design around, whereas broad claims may attract oppositions.

2. Similar and Related Patents

Isolating patent documents with similar claims or overlapping subject matter reveals whether UA100225 is part of a robust patent family or an isolated portfolio. Such documents can include:

  • Prior Art Documents:
    Existing patents or publications prior to filing that could challenge novelty or inventive step.

  • Competitor Patents:
    Other patents on similar chemical entities or delivery systems, influencing competitive strategy.

3. Patent Validity and Enforcement

The enforceability of UA100225 depends on:

  • Availability of prior art challenges:
    Any prior disclosures that anticipate the invention may threaten validity.

  • Maintained maintenance fees:
    Ensuring the patent remains active.

  • Claim scope and clarity:
    Well-drafted claims withstand legal scrutiny better.


Strategic Considerations

  • Infringement Risks:
    Competitors producing similar compounds or formulations within the claims’ scope risk infringement, enabling enforcement actions within Ukraine.

  • Licensing Opportunities:
    The patent’s claims may permit licensing agreements, particularly if the protected invention aligns with unmet medical needs.

  • Expiry and Lifecycle Management:
    Patent UA100225’s expiry date influences market exclusivity timelines. Regular maintenance is critical.


Conclusion

Patent UA100225 provides Ukrainian-based exclusivity primarily centered on a specific pharmaceutical invention, likely involving a chemical compound or formulation. Its scope, governed by carefully drafted claims, defines the boundary within which competitors cannot operate without risk. For patent owners, strategic management involves monitoring claim validity, exploring licensing, and safeguarding against infringement. For competitors, understanding its scope informs design-around strategies and freedom-to-operate assessments.


Key Takeaways

  • Claim Language and Scope Are Critical: Precise claims determine the extent of legal protection; broad claims afford more coverage but may be harder to defend or patentably patent.

  • Landscape Awareness Is Vital: Recognizing overlapping patents and prior art guides patent validity, licensing, and infringement strategies within Ukraine.

  • Patent Maintenance and Opposition Are Ongoing Concerns: Securing patent rights involves active management, including timely fee payments and vigilance for challenges.

  • International Considerations Matter: The patent’s relation to broader patent families influences global strategic planning.

  • Legal and Commercial Strategies Must Align: Enforcing patent rights or designing around the patent requires detailed knowledge of the claims and landscape.


FAQs

1. What is the typical scope of pharmaceutical patents like UA100225?
Such patents usually cover specific chemical entities (compounds), their pharmaceutical formulations, synthesis methods, or therapeutic uses. The scope depends on how broad the independent claims are drafted.

2. How can competitors work around the patent UA100225?
By designing chemical analogs not covered by the patent claims, modifying synthesis routes, or developing alternative formulations outside the scope of the claims, competitors can avoid infringement.

3. What are the risks of patent invalidation in Ukraine?
Prior art disclosures, obviousness, or lack of inventive step can challenge patent validity. Maintaining current patentability standards and monitoring patent scope reduce these risks.

4. How does patent UA100225 fit into Ukraine's broader drug patent landscape?
It likely forms part of a network of patents covering similar chemical classes or formulations. Mapping related patents enables strategic planning for market entry or licensing.

5. When does the patent UA100225 expire?
Under Ukrainian patent law, patents generally last 20 years from the filing date, subject to maintenance fees. The exact expiry date can be confirmed through patent databases.


References

  1. State Patent Office of Ukraine. Patent database and official documentation.
  2. Ukrainian Patent Law, Law of Ukraine "On Intellectual Property" (2019).
  3. WIPO Patent Statistics and Patent Landscape Reports.
  4. European Patent Office. Patent drafting and claim interpretation guidelines.

[Note: Specific claim details and citations are limited due to access restrictions; for precise claim language, consult the official patent document.]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.